China's Shrinking Population Poses New Challenge For Pharma

Also, More COVID Drug Approvals

 
• By Brian Yang

For the first time in 61 years, China has reported its population is shrinking and the new demographic shift is likely to have a far-reaching impact on the pharma sector. Meanwhile, regulators have accelerated the approval of new COVID-19 drugs to relieve acute shortages.

China population shrinking for the first time in six decades, creates profound impact to drug making sector
Chinese population shrinks for the first time in six decades • Source: Shutterstock

More from China

More from Asia